Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy.
Ghasemi A, Martinez-Usatorre A, Li L, Hicham M, Guichard A, Marcone R, Fournier N, Torchia B, Martinez Bedoya D, Davanture S, Fernández-Vaquero M, Fan C, Janzen J, Mohammadzadeh Y, Genolet R, Mansouri N, Wenes M, Migliorini D, Heikenwalder M, De Palma M. Ghasemi A, et al. Among authors: migliorini d. Nat Cancer. 2024 Feb;5(2):240-261. doi: 10.1038/s43018-023-00668-y. Epub 2023 Nov 23. Nat Cancer. 2024. PMID: 37996514 Free PMC article.
Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma.
Dutoit V, Migliorini D, Ranzanici G, Marinari E, Widmer V, Lobrinus JA, Momjian S, Costello J, Walker PR, Okada H, Weinschenk T, Herold-Mende C, Dietrich PY. Dutoit V, et al. Among authors: migliorini d. Oncoimmunology. 2017 Nov 7;7(2):e1391972. doi: 10.1080/2162402X.2017.1391972. eCollection 2018. Oncoimmunology. 2017. PMID: 29308320 Free PMC article.
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients.
Migliorini D, Dutoit V, Allard M, Grandjean Hallez N, Marinari E, Widmer V, Philippin G, Corlazzoli F, Gustave R, Kreutzfeldt M, Blazek N, Wasem J, Hottinger A, Koka A, Momjian S, Lobrinus A, Merkler D, Vargas MI, Walker PR, Patrikidou A, Dietrich PY. Migliorini D, et al. Neuro Oncol. 2019 Jul 11;21(7):923-933. doi: 10.1093/neuonc/noz040. Neuro Oncol. 2019. PMID: 30753611 Free PMC article. Clinical Trial.
Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread.
Marinari E, Dutoit V, Nikolaev S, Vargas MI, Schaller K, Lobrinus JA, Dietrich PY, Tsantoulis P, Migliorini D. Marinari E, et al. Among authors: migliorini d. Neurol Genet. 2021 Feb 15;7(2):e561. doi: 10.1212/NXG.0000000000000561. eCollection 2021 Apr. Neurol Genet. 2021. PMID: 33898738 Free PMC article.
ChatGPT in glioma adjuvant therapy decision making: ready to assume the role of a doctor in the tumour board?
Haemmerli J, Sveikata L, Nouri A, May A, Egervari K, Freyschlag C, Lobrinus JA, Migliorini D, Momjian S, Sanda N, Schaller K, Tran S, Yeung J, Bijlenga P. Haemmerli J, et al. Among authors: migliorini d. BMJ Health Care Inform. 2023 Jun;30(1):e100775. doi: 10.1136/bmjhci-2023-100775. BMJ Health Care Inform. 2023. PMID: 37399360 Free PMC article.
PTPRZ1-Targeting RNA CAR T Cells Exert Antigen-Specific and Bystander Antitumor Activity in Glioblastoma.
Martinez Bedoya D, Marinari E, Davanture S, Castillo Cantero L, Erraiss S, Dockerill M, Barluenga S, Winssinger N, Schaller K, Bijlenga P, Momjian S, Voize C, Tissot SR, Kandalaft LE, Hammel P, Cosson P, Walker PR, Dutoit V, Migliorini D. Martinez Bedoya D, et al. Among authors: migliorini d. Cancer Immunol Res. 2024 Dec 3;12(12):1718-1735. doi: 10.1158/2326-6066.CIR-23-1094. Cancer Immunol Res. 2024. PMID: 39269445
108 results